BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7092665)

  • 21. A comparison of the reduction in the K+ activity of the scala media produced by furosemide and ouabain.
    Shugyo A; Mori N; Matsunaga T
    Eur Arch Otorhinolaryngol; 1990; 248(2):79-81. PubMed ID: 2282218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of furosemide on the endocochlear potential in ears with experimentally induced endolymphatic hydrops.
    Ito Z; Kusakari J; Takeyama M; Nishikawa N; Hara A; Nakata H
    Acta Otolaryngol Suppl; 1991; 481():83-7. PubMed ID: 1927494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of furosemide on endocochlear potentials, auditory action potentials and summating potentials and the changes of inner ear pathology].
    Wang L
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(2):70-2, 124. PubMed ID: 1419180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of vanadate on EP and its distribution in guinea pig cochlea.
    Nakano T; Morimitsu T
    Acta Otolaryngol Suppl; 1988; 456():117-23. PubMed ID: 3227821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation mechanism of the negative endocochlear potential during early stage of anoxia.
    Kusakari J; Rokugo M; Kambayashi J; Arakawa E; Ohyama K; Hara A; Kawamoto K
    ORL J Otorhinolaryngol Relat Spec; 1983; 45(4):195-202. PubMed ID: 6603600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of furosemide on intracochlear oxygen tension in the guinea pig.
    Liu JX; Zhou XN; Yuan YG
    Eur Arch Otorhinolaryngol; 1996; 253(6):367-70. PubMed ID: 8858263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of kanamycin sulfate on the endocochlear dc potential of guinea pigs.
    Asakuma S; Lowry LD; Snow JB
    Arch Otolaryngol; 1979 Mar; 105(3):145-8. PubMed ID: 420653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endocochlear DC potential in kanamycin-sulfate-treated guinea pigs.
    Asakuma S; Lowry LD; Snow JB
    Surg Forum; 1977; 28():510-1. PubMed ID: 617522
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental study of the mechanism of the decrease in endocochlear d.c. potential after administration of nitrogen mustard-N-oxide.
    Asakuma S; Yoshida M; Toriya Y; Hirashima K
    Acta Otolaryngol; 1984; 97(3-4):273-82. PubMed ID: 6720303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Support of cochlear metabolic and ion transport processes solely by perilymphatic perfusion.
    Marcus DC; Kobayashi T; Rokugo M; Marcus NY; Thalmann I; Thalmann R
    Hear Res; 1984 Sep; 15(3):287-92. PubMed ID: 6501116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Math1 gene therapy for kanamycin and furosemide-induced deaf guinea pigs].
    Zhang XF; Yang SM; Han DY; Guo WW; Sun JH; Gao J; Sun DX; Sun AL; Li Z; Wei XN
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Jul; 48(7):584-8. PubMed ID: 24313209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanism of lack of development of negative endocochlear potential in guinea pigs with hair cell loss.
    Komune S; Nakagawa T; Hisashi K; Kimitsuki T; Uemura T
    Hear Res; 1993 Nov; 70(2):197-204. PubMed ID: 8294264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combined effect of cisplatin and furosemide on hearing function in guinea pigs.
    Laurell G; Engström B
    Hear Res; 1989 Mar; 38(1-2):19-26. PubMed ID: 2708156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetraethylammonium effects on cochlear potentials in the guinea pig.
    van Emst MG; Klis SF; Smoorenburg GF
    Hear Res; 1995 Aug; 88(1-2):27-35. PubMed ID: 8576000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endolymphatic perfusion with EGTA-acetoxymethyl ester inhibits asphyxia- and furosemide-induced decrease in endocochlear potential in guinea pigs.
    Mineharu A; Mori Y; Nimura Y; Takamaki A; Araki M; Yamaji J; Yoshida R; Takenaka H; Kubota T
    Jpn J Physiol; 2005 Feb; 55(1):53-60. PubMed ID: 15796789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of forskolin to elevate the endocochlear potential in experimental endolymphatic hydrops of the guinea pig.
    Kitano I; Mori N; Nario K; Umemoto M; Sakagami M; Fukazawa K; Matsunaga T
    Acta Otolaryngol Suppl; 1998; 533():9-11. PubMed ID: 9657302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The difference in endocochlear and endolymphatic sac d.c. potentials in response to furosemide and canrenoate as diuretics.
    Mori N; Uozumi N; Yura K; Sakai S
    Eur Arch Otorhinolaryngol; 1990; 247(6):371-3. PubMed ID: 2278704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism generating endocochlear potential: role played by intermediate cells in stria vascularis.
    Takeuchi S; Ando M; Kakigi A
    Biophys J; 2000 Nov; 79(5):2572-82. PubMed ID: 11053131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissociation of the cochlear microphonics and endocochlear potential after injection of ethacrynic acid.
    Komune S; Morimitsu T
    Arch Otorhinolaryngol; 1985; 241(2):149-56. PubMed ID: 3977766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of various vanadium compounds on cochlear potentials.
    Nakano T; Morimitsu T
    Acta Otolaryngol Suppl; 1988; 456():132-6. PubMed ID: 2852429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.